SENATE FLOOR VERSION - SB668 SFLR Page 1
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
February 23, 2023
COMMITTEE SUBSTITUTE
FOR
SENATE BILL NO. 668 By: Standridge
An Act relating to the Uniform Controlled Dangerous
Substances Act; amending 63 O.S. 2021, Section 2-322,
which relates to precursor substances requiring
permit or license; removing certain drugs from
requiring certain permitting or licensing ; and
providing an effective date .
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S . 2021, Section 2-322, is
amended to read as follows:
Section 2-322. A. No person or business shall pos sess, sell,
manufacture, transfer, or otherwise fur nish any of the following
precursor substances without first having a permit or license issued
by the Director of the Oklahoma State Bureau of Narcotics and
Dangerous Drugs Control, except as provided in S ection 2-327 of this
title:
1. D-Lysergic acid;
2. Ergotamine and its salts;
3. Ergonovine and its salt s;
4. Methylamine;
SENATE FLOOR VERSION - SB668 SFLR Page 2
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
5. Ethylamine;
6. Phenyl-2-Propanone;
7. Phenylacetic acid and its salts;
8. Ephedrine, its salts, optical isomers and salts o f optical
isomers;
9. Norpseudoephedrine, its salt s, optical isomers, and salts of
optical isomers;
10. Phenylpropanolamine, its salts, optical isome rs and salts
of optical isomers;
11. 9. Benzyl cyanide;
12. 10. N-methylephedrine, its salts, optical i somers, and
salts of optical isomers;
13. Pseudoephedrine, its salts, optical isomers and salts of
optical isomers;
14. 11. Chloroephedrine, its salt s, optical isomers, and salts
of optical isomers;
15. 12. Piperidine and its salts;
16. 13. Pyrrolidine and its salts;
17. 14. Propionic anhydride;
18. 15. Isosafrole;
19. 16. Safrole;
20. 17. Piperonal; and
21. 18. Red Phosphorus.
SENATE FLOOR VERSION - SB668 SFLR Page 3
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
B. Upon completion of an application for a license pursuant to
Section 2-323 of this title, or a permit pursuant to Section 2-324
of this title, the Director of the Oklahoma State Bureau of
Narcotics and Dangerous Drugs Control shall either grant or deny
such license or permit. A denial of an application for a permit or
license shall be handled as provided by Section 2 -325 of this title.
SECTION 2. This act shall become effective November 1, 2023.
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICE S
February 23, 2023 - DO PASS AS AMENDED BY CS